Breast Cancer Research and Treatment

, Volume 92, Issue 2, pp 141–149

GREB1 is a critical regulator of hormone dependent breast cancer growth

  • James M. Rae
  • Michael D. Johnson
  • Joshua O. Scheys
  • Kevin E. Cordero
  • José M. Larios
  • Marc E. Lippman


Background Estrogen plays a central role in breast cancer pathogenesis and many potent risk factors for the development of the disease can be explained in terms of increased lifetime exposure to estrogen. Although estrogen regulated genes have been identified, those critically involved in growth regulation remain elusive.

Methods.  To identify candidate genes involved in estrogen stimulated breast cancer growth, DNA microarray based gene expression profiles were generated from three estrogen receptor α (ERα) positive breast cancer cell lines grown under multiple stimulatory and inhibitory conditions.

Results  Only three genes were significantly induced by 17β-estradiol (E2) relative to control in all three cell lines: GREB1, stromal cell-derived factor 1 (SDF-1) and trefoil factor 1 (pS2). Quantitative real-time PCR assays confirmed that in all three cell lines, GREB1 was induced by E2, but not by the antiestrogens tamoxifen (TAM) or ICI 182,780. GREB1 expression level was strongly correlated with ERα positivity in 39 breast cancer cell lines of known ERα expression status. GREB1 induction by E2 was rapid (7.3 fold by 2 h for MCF-7) and mirrored the fraction of cells entering S-phase when released from an estrogen deprivation induced cell arrest. Suppression of GREB1 using siRNA blocked estrogen induced growth in MCF-7 cells and caused a paradoxical E2 induced growth inhibition.

Conclusion  These data suggest that GREB1 is critically involved in the estrogen induced growth of breast cancer cells and has the potential of being a clinical marker for response to endocrine therapy as well as a potential therapeutic target.

Key words

breast cancer estrogen induced growth GREB1 hormonal control 





estrogen receptor alpha


estrogen receptor beta


fetal bovine serum


gene regulated in breast cancer 1


trefoil factor 1


stromal cell-derived factor 1


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Cancer Society. Cancer Facts and Figures 2004, 2004.Google Scholar
  2. 2.
    Elledge, RM, Fuqua, SA 2000

    Estrogen and progesterone receptors

    Harris, JLippman, MEMorrow, MOsborne, C eds. Diseases of the BreastLippincott, Williams and WilkinsPhiladelphia471488
    Google Scholar
  3. 3.
    Jordan, VC 2003Tamoxifen: a most unlikely pioneering medicineNat Rev Drug Discov2205213Google Scholar
  4. 4.
    McDonnell, DP, Norris, JD 2002Connections and regulation of the human estrogen receptorScience29616421644Google Scholar
  5. 5.
    Johnson, MD, Zuo, H, Lee, KH, Trebley, JP, Rae, JM, Weatherman, RV, Desta, Z, Flockhart, DA, Skaar, TC 2004Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifenBreast Cancer Res Treat85151159Google Scholar
  6. 6.
    Rae, JM, Lippman, ME 2004Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitorsBreast Cancer Res Treat8399107Google Scholar
  7. 7.
    Li, C, Wong, WH 2001Model-based analysis of oligonucleotide arrays: expression index computation and outlier detectionProc Natl Acad Sci USA983136Google Scholar
  8. 8.
    Bosma, AJ, Weigelt, B, Lambrechts, AC, Verhagen, OJ, Pruntel, R, Hart, AA, Rodenhuis, S, van’t Veer, VJ 2002Detection of circulating breast tumor cells by differential expression of marker genesClin Cancer Res818711877Google Scholar
  9. 9.
    Laborda, J 199136B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PONucleic Acids Res193998Google Scholar
  10. 10.
    Livak, KJ, Schmittgen, TD 2001Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) MethodMethods25402408Google Scholar
  11. 11.
    Clarke, R, Brunner, N, Katz, D, Glanz, P, Dickson, RB, Lippman, ME, Kern, FG 1989The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivoMol Endocrinol3372380Google Scholar
  12. 12.
    Workman, P, Balmain, A, Hickman, JA, McNally, NJ, Rohas, AM, Mitchison, NA, Pierrepoint, CF, Raymond, R, Rowlatt, C, Stephens, TC 1988UKCCCR guidelines for the welfare of animals in experimental neoplasiaLab Anim22195201Google Scholar
  13. 13.
    Lefebvre, O, Chenard, MP, Masson, R, Linares, J, Dierich, A, LeMeur, M, Wendling, C, Tomasetto, C, Chambon, P, Rio, MC 1996Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil proteinScience274259262Google Scholar
  14. 14.
    Hall, JM, Korach, KS 2003Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cellsMol Endocrinol17792803Google Scholar
  15. 15.
    Ghosh, MG, Thompson, DA, Weigel, RJ 2000PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancerCancer Res6063676375Google Scholar
  16. 16.
    Lacroix, M, Leclercq, G 2004Relevance of breast cancer cell lines as models for breast tumours: an updateBreast Cancer Res Treat83249289Google Scholar
  17. 17.
    Soulez, M, Parker, MG 2001Identification of novel oestrogen receptor target genes in human ZR75–1 breast cancer cells by expression profilingJ Mol Endocrinol27259274Google Scholar
  18. 18.
    Inoue, A, Yoshida, N, Omoto, Y, Oguchi, S, Yamori, T, Kiyama, R, Hayashi, S 2002Development of cDNA microarray for expression profiling of estrogen-responsive genesJ Mol Endocrinol29175192Google Scholar
  19. 19.
    Frasor, J, Danes, JM, Komm, B, Chang, KC, Lyttle, CR, Katzenellenbogen, BS 2003Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotypeEndocrinology14445624574Google Scholar
  20. 20.
    Frasor, J, Stossi, F, Danes, JM, Komm, B, Lyttle, CR, Katzenellenbogen, BS 2004Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cellsCancer Res6415221533Google Scholar
  21. 21.
    Wang, DY, Fulthorpe, R, Liss, SN, Edwards, EA 2004Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1Mol Endocrinol18402411Google Scholar
  22. 22.
    Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS: Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor α or estrogen receptor β in human osteosarcoma cells: distinct and common target genes for these receptors**. Endocrinology 2004Google Scholar
  23. 23.
    Brown, AM, Jeltsch, JM, Roberts, M, Chambon, P 1984Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7Proc Natl Acad Sci USA8163446348Google Scholar
  24. 24.
    Foekens, JA, Portengen, H, Look, MP, Putten, WL, Thirion, B, Bontenbal, M, Klijn, JG 1994Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancerBr J Cancer7012171223Google Scholar
  25. 25.
    Henry, JA, Piggott, NH, Mallick, UK, Nicholson, S, Farndon, JR, Westley, BR,  et al. 1991pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine responseBr J Cancer63615622Google Scholar
  26. 26.
    Oberlin, E, Amara, A, Bachelerie, F, Bessia, C, Virelizier, JL, Arenzana-Seisdedos, F, Schwartz, O, Heard, JM, Clark-Lewis, I, Legler, DF, Loetscher, M, Baggiolini, M, Moser, B 1996The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1Nature382833835Google Scholar
  27. 27.
    Muller, A, Homey, B, Soto, H, Ge, N, Catron, D, Buchanan, ME, McClanahan, T, Murphy, E, Yuan, W, Wagner, SN, Barrera, JL, Mohar, A, Verastegui, E, Zlotnik, A 2001Involvement of chemokine receptors in breast cancer metastasisNature4105056Google Scholar
  28. 28.
    Nagase, T, Ishikawa, K, Miyajima, N, Tanaka, A, Kotani, H, Nomura, N, Ohara, O 1998Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitroDNA Res53139Google Scholar
  29. 29.
    Peterfy, M, Phan, J, Oswell, GM, Xu, P, Reue, K 1999Genetic, physical, and transcript map of the fld region on mouse chromosome 12Genomics62436444Google Scholar
  30. 30.
    Lin, CY, Strom, A, Vega, VB, Kong, SL, Yeo, AL, Thomsen, JS, Chan, WC, Doray, B, Bangarusamy, DK, Ramasamy, A, Vergara, LA, Tang, S, Chong, A, Bajic, VB, Miller, LD, Gustafsson, JA, Liu, ET 2004Discovery of estrogen receptor alpha target genes and response elements in breast tumor cellsGenome Biol5R66Google Scholar
  31. 31.
    Chi, JT, Chang, HY, Wang, NN, Chang, DS, Dunphy, N, Brown, PO 2003Genomewide view of gene silencing by small interfering RNAsProc Natl Acad Sci USA10063436346Google Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • James M. Rae
    • 2
  • Michael D. Johnson
    • 1
  • Joshua O. Scheys
    • 2
  • Kevin E. Cordero
    • 2
  • José M. Larios
    • 2
  • Marc E. Lippman
    • 2
  1. 1.Department of OncologyGeorgetown UniversityWashington
  2. 2.Department of Internal Medicine, Division of Hematology and OncologyUniversity of Michigan Medical CenterAnn ArborUSA

Personalised recommendations